Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
80.3M
-
Shares change
-
-802K
-
Total reported value, excl. options
-
$1.17B
-
Value change
-
-$18.1M
-
Put/Call ratio
-
0.04
-
Number of buys
-
92
-
Number of sells
-
-79
-
Price
-
$14.51
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2022
215 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q4 2022.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.3M shares
of 93.1M outstanding shares and own 86.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14.4M shares), VANGUARD GROUP INC (9.31M shares), Camber Capital Management LP (7M shares), WELLINGTON MANAGEMENT GROUP LLP (6.79M shares), STATE STREET CORP (5.02M shares), EARNEST PARTNERS LLC (3.3M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (3.1M shares), BANK OF AMERICA CORP /DE/ (2.65M shares), DIMENSIONAL FUND ADVISORS LP (2.63M shares), and DISCIPLINED GROWTH INVESTORS INC /MN (2.27M shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.